Literature DB >> 8450839

Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex.

J M Rosenberg1, P H Sato.   

Abstract

We previously reported that mRNA loses the ability to direct in vitro peptide synthesis after incubation with cisplatin. The present study was designed to determine the step in translation that is affected. The rates of translation reactions inhibited by cisplatin were biphasic, having an initial rate comparable to that of the uninhibited reaction before decreasing. Analysis of cisplatin-inhibited reactions in sucrose density gradients showed a decrease in polyribosome formation. These results are consistent with an inhibition of the initiation step of protein synthesis. Individual steps in initiation were tested by analyzing the formation of ribosomal subunits in sucrose gradients that resolve the incomplete complexes. Cisplatin caused an accumulation of 48 S particles accompanied by a decreased amount of completed 80 S initiation complexes. Similar results were obtained in experiments utilizing radiolabeled methionine or mRNA. We conclude that cisplatin blocks the initiation of translation by preventing the joining of the 60 S ribosomal subunit to the 48 S preinitiation subunit.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450839

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae.

Authors:  Alethia A Hostetter; Maire F Osborn; Victoria J DeRose
Journal:  ACS Chem Biol       Date:  2011-11-15       Impact factor: 5.100

Review 2.  Binding of kinetically inert metal ions to RNA: the case of platinum(II).

Authors:  Erich G Chapman; Alethia A Hostetter; Maire F Osborn; Amanda L Miller; Victoria J DeRose
Journal:  Met Ions Life Sci       Date:  2011

3.  Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin.

Authors:  Alethia A Hostetter; Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

4.  Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.

Authors:  Hanayo Kawai; Waichi Sato; Yukio Yuzawa; Tomoki Kosugi; Seiichi Matsuo; Yoshifumi Takei; Kenji Kadomatsu; Takashi Muramatsu
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells.

Authors:  Juan D Chavez; Michael R Hoopmann; Chad R Weisbrod; Kohji Takara; James E Bruce
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

6.  Cisplatin Targeting of Bacterial Ribosomal RNA Hairpins.

Authors:  Gayani N P Dedduwa-Mudalige; Christine S Chow
Journal:  Int J Mol Sci       Date:  2015-09-07       Impact factor: 5.923

7.  Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.

Authors:  Cristina Mari; Vanessa Pierroz; Stefano Ferrari; Gilles Gasser
Journal:  Chem Sci       Date:  2015-01-13       Impact factor: 9.825

8.  Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping.

Authors:  Maire F Osborn; Jonathan D White; Michael M Haley; Victoria J DeRose
Journal:  ACS Chem Biol       Date:  2014-08-15       Impact factor: 5.100

9.  Insights into RNA binding by the anticancer drug cisplatin from the crystal structure of cisplatin-modified ribosome.

Authors:  Sergey V Melnikov; Dieter Söll; Thomas A Steitz; Yury S Polikanov
Journal:  Nucleic Acids Res       Date:  2016-04-13       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.